downsides of glp-1 Do The Benefits Drugs OutWeigh the Negatives? what are the long term

13 In addition to being recommended in patients with ASCVD, GLP-1 receptor agonists are recommended for consideration as an add-on to metformin in patients without established ASCVD in whom there is a compelling need to minimize hypoglycemia, minimize weight gain, or promote weight loss

However, the safety and efficacy of such combinations require careful evaluation

Food and Drug Administration (FDA) has approved it to treat common mental health conditions, including Generalized Anxiety Disorder (GAD) and depression (especially, Major Depressive Disorder)

This approach extends to our use of peptides and other therapeutic options

The specificity of ipamorelin makes this compound a very interesting candidate for future clinical development.[3] Cititations: [1] Bowers CY, Momany F, Reynolds GA

CJC-1295 initiates a broad GH release, and Ipamorelin (no DAC) enhances and extends this effect by acting on separate signaling pathways